Comparison between the effect of Two Regimens for Hepatitis C Treatment (Qurevo and Ribavirin) and (Sofosbuvir, Daclatsvir and Ribavirin) on Patients above and below the Age of 60 Years

Journal Title: The Egyptian Journal of Hospital Medicine - Year 2018, Vol 72, Issue 10

Abstract

<strong>Background:</strong> the goal of antiviral treatment is to prevent complications of the disease, mainly cirrhosis and HCC. New therapy options, known as direct acting antiviral (DAA) regimens, offer the promise of increased success rates complimented by shorter treatment durations, improve side effect profiles, and simplified treatment monitoring. <strong>Aim of the Work:</strong> to compare between the effect of oral antiviral treatment especially (Quervo and Ribavirin) and (Sofosbuvir, Daclatasvir and Ribavirin) between elderly patients above 60 years and young people below this age as regard: Response to treatment, Development of complication. <strong>Patients and Methods:</strong> the study was conducted on 100 Egyptian patients they were divided into 2 groups each one received one of the two treatment regimens then each group divided into 2 subgroups, subgroup A include patients below 60 years and subgroup B include patients above 60 years. The selected patients were subjected to History taking, Complete physical examination, Pelviabdominal ultrasound, Laboratory investigations: complete blood count, bilirubin and liver enzymes before and after treatment, INR, creatinine, albumin, HBs Ag, HIV antibodies and Alpha feto proteins, HCV RNA. <strong>Results:</strong> there is no significant difference between two treatment regimens. Both regimens show cure rate about 94%, 96% achieved SVR with (sofosbuvir daclatasvir and ribavirin regimen), (quervo and ribavirin regimen) respectively. Both regimens are effective in elderly patients above 60 years as young patients below this age in both regimens, response of treatment in both regimens in elderly patients above 60 years is 96%. Gender doesn't affect treatment outcome. Anemia develop in 34% of patients receiving sofosbuvir, daclatasvir and ribavirin regimen, and in 58% of patients receiving quervo and ribavirin regimen. Females developed anemia more frequent than males in both regimens. Both regimens developed hepatobiliary complication, 12%, 18% developed hyperbilirubinemia with (sofosbuvir daclatasvir and ribavirin regimen), (quervo and ribavirin regimen) respectively. <strong>Conclusion:</strong> treatment with (sofosbuvir daclatasvir and ribavirin regimen) or (quervo and ribavirin regimen) is highly effective with little differences between them; also age and gender have no role in achieving SVR. Complications such as anemia and hyperbilirubinemia occur in treatment with both regimens and more frequent with (quervo and ribavirin regimen).

Authors and Affiliations

Eman Helal

Keywords

Related Articles

Urinary Tract Infection in Patients with Diabetes Mellitus

Background: urinary tract infections (UTI) are one of the most common types of bacterial infection in patients with diabetes mellitus (DM). There are certain aspects to diabetes that makes it a risk factor for getting ur...

The Frequency of Palmaris Longus Absence among Female Students in King Faisal University in Al-Ahsa, Saudi Arabia

<strong>Background: </strong>Palmaris longus (PL) is one of the forearm muscles that lie between the flexor carpi ulnaris and the flexor carpi radialis muscles. PL action is flexion of the hand at the wrist and making th...

Evaluation of Safety and Efficacy of Radiofrequency Lesioning of Thoracic Dorsal Root Ganglion in Chest Cancer Pain Patients

Background: asymptomatic bacteriuria (ASB) during pregnancy is the primary cause of acute pyelonephritis, preterm labor, low birth weight fetus, etc., if left untreated. Adequate and early treatment reduces the prevalenc...

Diagnostic Performance of Point of Care Ultrasonography in Identifying Etiology of Respiratory Distress in Neonates

Background: Numerous studies have shown the role of lung ultrasound in identifying etiology of respiratory distress in neonates. Aim of the Work: was to detect the efficacy of ultrasonography versus x-ray in identifying...

Primary Immuno-Deficiencies in Pediatrics

<strong>Introduction: </strong>There are many different types of primary immunodeficiency syndromes, with an overall prevalence of one in every 2,000 children in the United States. These syndromes are broadly classified...

Download PDF file
  • EP ID EP584339
  • DOI 10.12816/ejhm.2018.11284
  • Views 123
  • Downloads 0

How To Cite

Eman Helal (2018). Comparison between the effect of Two Regimens for Hepatitis C Treatment (Qurevo and Ribavirin) and (Sofosbuvir, Daclatsvir and Ribavirin) on Patients above and below the Age of 60 Years. The Egyptian Journal of Hospital Medicine, 72(10), 5385-5390. https://europub.co.uk./articles/-A-584339